CA
NZ
UK
AU
IND
US
A group of Venrock Healthcare Capital Partners entities and two individual principals filed a Schedule 13G with the SEC on October 30, 2026, disclosing beneficial ownership of 6,850,237 shares of Lycia Therapeutics, Inc. common stock as of October 23, 2026.
A group of Venrock Healthcare entities and two individual managers filed a Schedule 13G with the SEC on October 30, 2026, disclosing beneficial ownership of 8,861,763 ordinary shares of Entera Bio Ltd. as of October 23, 2026.
Venrock Healthcare Capital Partners III, L.P. and affiliated entities filed a Form 4 with the SEC on October 30, 2026, disclosing five open-market purchases of Lycia Therapeutics, Inc. common stock executed between October 28 and October 30, 2026.
Director Dennis Podlesak of Syndax Pharmaceuticals Inc filed a Form 4 on October 30, 2026, reporting the exercise of 8,000 stock options and the same-day sale of 8,000 shares of common stock on October 29, 2026, pursuant to a Rule 10b5-1 plan.
Director Frances Arnold filed a Form 4 with the SEC on October 30, 2026, disclosing a sale of 82 shares of Alphabet Inc. Class C Capital Stock on October 29, 2026, executed under a pre-established Rule 10b5-1 trading plan.
Director James P. Holden filed a Form 4 with the SEC on October 30, 2026, reporting the acquisition of 38 shares of Snap-on Inc common stock under the company's Directors' 1993 Fee Plan.
Jason Murray Hulse, Co-Founder, CEO and Chairman of PACS Group, Inc., filed a Form 4 on October 30, 2026, disclosing the sale of 8,803 shares of common stock across two transactions on October 28 and October 29, 2026, pursuant to a Rule 10b5-1 trading …
Michelle Renee Lewis, Chief Accounting Officer of PACS Group, Inc., filed a Form 4 on October 30, 2026, disclosing the sale of a combined 11,828 shares of common stock across two transactions on October 28 and October 29, 2026, executed under a pre-established Rule …
Director and 10% owner Mark Hancock filed a Form 4 with the SEC on October 30, 2026, reporting the sale of 13,304 shares of PACS Group, Inc. common stock across two transactions on October 28 and October 29, 2026, executed under a pre-established Rule …
Matthew Eliot Clark, Executive Vice President and CFO of Cheesecake Factory Inc, filed a Form 4 on October 30, 2026, disclosing an option exercise and same-day sale of 23,832 shares of common stock on October 29, 2026.
Please wait processing your request...